Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).
scientific article published on 27 January 2012
Author/s
author: Axel Le Cesne, Jean-Yves Blay, Isabelle Ray-Coquard, Sophie Piperno-Neumann, Yves-Marie Robin, Nicolas Penel, Jacques-Olivier Bay, Christine Chevreau, Nicolas Isambert, Didier Cupissol, Emmanuelle Bompas, Olivier Collard, Guilhem Bousquet, Stéphanie Clisant, French Sarcoma Group (GSF/GETO)
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.